Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Cardiome Pharma Corp    COM   CA14159U3010

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in the discovery, development and commercialization of new therapies

Cardiome Pharma Corp. is a specialty pharmaceutical company.

It engages in the discovery, development and commercialization of cardiovascular therapies that will improve the health of patients suffering from heart disease.

Cardiome has two marketed products, BRINAVESS, approved in Europe and other territories for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults, and AGGRASTAT a reversible GP IIb/IIIa inhibitor indicated for use in patients with acute coronary syndrome.

The company was founded on December 12, 1986 and is headquartered in Vancouver, Canada.

Number of employees : 85 persons.
Sales per Businesses
20142015Delta
CAD (in Million)%CAD (in Million)%
Cardiovascular Therapies33.18100%26.75100% -19.37%
Sales per Regions
20142015Delta
CAD (in Million)%CAD (in Million)%
Rest of World17.3852.4%13.2349.4% -23.89%
Europe15.8047.6%13.5350.6% -14.41%
Managers
NameAgeSinceTitle
William L. Hunter, MD532007President, Chief Executive Officer & Director
William James O'Shea672014Chairman
Sheila M. Grant, MBA-2003Chief Operating Officer
Jennifer Archibald-2006Chief Financial Officer
Harold H. Shlevin, PhD672004Independent Director
Richard M. Glickman, PhD592006Lead Independent Director
Mark H. N. Corrigan, MD592015Director
Arthur H. Willms772015Independent Director
Robert James Meyer, MD-2015Director
Jürgen Polifka, PhD-2013General Manager-European Sales & Marketing
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 31,876,283 31,277,363 98.1% 0 0.0% 98.1%
Shareholders
NameEquities%
Westfield Capital Management Co. LP 5,423,142 17.0%
Putnam Investment Management LLC 3,683,481 11.6%
Tamarack Advisers LP 2,200,000 6.90%
Clough Capital Partners LP 2,044,653 6.41%
Stonepine Capital Management LLC 1,778,317 5.58%
Rock Springs Capital Management LP 1,190,000 3.73%
Fidelity Management & Research Co. 627,363 1.97%
William L. Hunter, MD 607,452 1.91%
AlphaOne Investment Services LLC 580,965 1.82%
Sabby Capital LLC 484,505 1.52%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Sector Biopharmaceuticals
1st jan.Capitalization (M$)
CARDIOME PHARMA CORP-5.30%92
BIOGEN INC0.41%61 954
CSL LIMITED0.67%34 476
ALEXION PHARMACEUTICAL..11.92%30 663
BIOMARIN PHARMACEUTICA..4.93%14 949
GRIFOLS SA1.75%13 046
CHONGQING ZHIFEI BIOLO..--.--%3 359
3SBIO INC-3.16%2 382
ABCAM PLC4.95%1 986
JIANGXI BOYA BIO-PHARM..--.--%1 952
PROMETIC LIFE SCIENCES..-5.26%1 027
HUGEL INC--.--%944
ANIKA THERAPEUTICS INC2.19%732
PHARMA MAR SA4.80%672
BIOTEST AG6.60%658
ARGOS THERAPEUTICS INC10.20%223
VIVUS, INC.4.35%126
MEDIWOUND LTD15.74%116
VERICEL CORP-1.67%94
ALIMERA SCIENCES INC17.59%82
CO DON AG24.09%69
Sector Biopharmaceuticals
Cardiome Pharma Corp : Connections
Cardiome Pharma Corp.
1441 Creekside Drive
6th Floor
Vancouver, BC V6J 4S7

Phone : +1.604.677.6905
Fax : +1.604.677.6915
Web : www.cardiome.com
© 2017 People , Fundamentals and Ownership